A vetted, regularly-updated directory of psychedelic and mental-health studies looking for U.S. military veterans — so the research that's for you can actually find you.
The Veterans Crisis Line is free, confidential, and available 24/7 — you don't have to be enrolled in VA care.
An Ethics Approved doctoral study at the California Institute of Integral Studies documenting how U.S. combat veterans with PTSD experience self-directed LSD microdosing. Veteran-led, fully confidential, remote participation. A five-minute screening tells you if you're eligible.
This is a retrospective study — researchers document veterans' existing experiences. Participation does not provide any substance.
Visit Microdosing Vets →Every study below is registered or run by a legitimate institution and open to U.S. veterans, and we point you to each study's official page — you enroll directly with that research team. Every listing is hand-reviewed. Studies marked In progress are already underway and closed to new participants — listed so you can see the full landscape of veteran research happening right now.
Community-informed, open-label group psilocybin-assisted therapy for PTSD. Eligibility specifically includes veterans and first responders.
Randomized, placebo-controlled trial testing ketamine and stellate ganglion block — alone or combined — for the TBI-associated headache and PTSD common in deployed service members. Sites include Walter Reed and Womack Army Medical Center.
Ethics Approved doctoral study documenting how U.S. combat veterans with PTSD experience self-directed LSD microdosing. Veteran-led, confidential, fully remote. (A psilocybin arm is planned.)
Open-label psilocybin-assisted therapy for veterans with PTSD, funded by the State of Texas.
Psilocybin with psychological support for veterans and first responders with co-occurring PTSD and alcohol use disorder.
The first FDA-approved trial of whole-mushroom psilocybin, with group dosing for veterans and first responders.
Phase 1 study combining psilocybin and MDMA for PTSD; veterans are eligible.
Phase 2 study comparing psilocybin paired with mindfulness-based cognitive therapy versus standard psychological support for PTSD. Open to adults with PTSD, including veterans.
VA study finding the optimal number of MDMA-assisted therapy cycles for veterans with PTSD.
Compares MDMA-assisted Cognitive Processing Therapy with standard CPT in veterans with severe PTSD.
MDMA-assisted therapy for veterans with moderate-to-severe PTSD.
The first federal VA-run MDMA trial, for veterans with co-occurring PTSD and alcohol use disorder.
Open-label MDMA-assisted therapy for veterans with co-occurring alcohol use disorder and PTSD.
DoD-funded MDMA plus a two-week massed Prolonged Exposure protocol for service members and veterans.
Phase 3 MDMA with massed Prolonged Exposure, sponsored by the veteran nonprofit Healing Breakthrough.
Outpatient ketamine infusion for active-duty service members, veterans, and retirees with chronic neuropathic pain and PTSD.
VA study of ketamine-assisted integrative treatment for veterans with chronic low back pain and co-occurring depression.
Explores how veterans experience ketamine-assisted psychotherapy for depression and end-of-life distress.
An anonymous 5–15 minute online survey for veterans who have used psychedelics therapeutically. No travel, fully remote.
Large multi-site VA Phase 3 psilocybin trial for veterans with treatment-resistant depression. Begins July 2026.
Phase 2 open-label MDMA-assisted therapy for veterans with PTSD, comparing individual and group settings. Now recruiting in Rockville, Maryland.
Subanesthetic ketamine for depression and PTSD in veterans with mild-to-moderate traumatic brain injury.
Open-label Phase 2 trial of psilocybin-assisted therapy in U.S. military veterans with PTSD. Underway now — closed to new enrollment; results pending.
Observational Stanford study following veterans with repeated blast/combat head trauma before and after ibogaine–magnesium therapy. Findings were published in Nature Medicine (2024). Underway — closed to new enrollment.
These PTSD studies aren’t run specifically for veterans, but their criteria allow veterans to join — useful if you’re not near a veteran-specific site. Eligibility is always confirmed directly with the research team.
Phase 2 open-label psilocybin-assisted therapy for women with PTSD from sexual assault — directly relevant to women veterans and survivors of military sexual trauma. Open to the public; women only.
Open-label psilocybin-assisted therapy testing safety and tolerability in people with spinal cord injury and depression, run at a VA medical center.
MDMA-assisted therapy for women with co-occurring PTSD and opioid use disorder in the postpartum period.
Early-phase trial of ketamine in patients hospitalized with severe traumatic brain injury.
Randomized, placebo-controlled trial of IV ketamine for depression in veterans with Parkinson's disease.
Phase 4 trial of ketamine during orthopedic trauma surgery to reduce pain, opioid use, and post-injury depression and PTSD.
If you know of an actively-recruiting study that belongs here, tell us. Every suggestion is reviewed before it goes on the list.
Email research@psychedelicvets.comA study only appears here after it clears every one of these checks. The vetting is the point — it's what makes this more useful than a raw registry search.
New candidates are pulled weekly from ClinicalTrials.gov and reviewed against university and nonprofit sources by a person before they're published. Studies that don't clearly meet the bar wait in a review queue rather than going live automatically.
This directory is for education and navigation only. Psychedelic Vets is not affiliated with the studies listed and does not run them, endorse them, or collect any of your health information here. When you click through to a study, you're handed off entirely to that research team's own official page and its approved consent process. Nothing on this page is medical advice, and nothing here facilitates obtaining any controlled substance.
Beyond individual studies, these veteran-focused nonprofits run, fund, or route veterans into psychedelic-assisted research and care. They're independent of Psychedelic Vets — we link to their official pages so you can apply through their own process.
Guided psilocybin retreats in Oregon and international ayahuasca/psilocybin programs for veterans, with coaching and integration. Applications open on a quarterly cycle.
Apply / learn more →Funds psychedelic-assisted therapy, preparation, and integration for veterans and spouses. New grant applications are temporarily paused due to demand — watch for reopening.
Grant info →Veteran-focused nonprofit funding MDMA-assisted therapy research and advocating for access through the VA. Sponsor of an active Phase 3 MDMA study.
Learn more →Listing here is navigation, not endorsement or facilitation. Some programs operate outside the U.S. where laws differ; review each organization's own eligibility, safety, and legal information before applying.
New veteran studies open all the time — and several big ones start later in 2026. Get a heads-up when they do.
The week in veteran psychedelic research — what's newly recruiting, what the latest studies found, and one thing worth knowing. A two-minute read, every Wednesday.
Joining never enrolls you in a study — that always happens with the research team.
This list is checked against ClinicalTrials.gov every week and stays open to every veteran, with no account and no paywall. Membership is what pays for that — and funds the research itself. Any amount, from $10 a month.
See how it works →Joining the list never enrolls you in any study — that always happens directly with the research team, through their own consent process.
Research is one path. Whether or not a study fits, there's a peer-curated library of crisis lines, free mental-health care, books, films, somatic and integration resources, and treatment programs for veterans.
Explore the resource library →
